To Accelerate the Process of Brain Death Determination in China Through the Strategy and Practice of Establishing Demonstration Hospitals.

IF 3.1 3区医学 Q2 CLINICAL NEUROLOGY

Neurocritical Care Pub Date : 2024-08-01 Epub Date: 2024-01-05 DOI:10.1007/s12028-023-01908-w

Yingying Su, Weibi Chen, Yan Zhang, Linlin Fan, Gang Liu, Fei Tian, Huijin Huang, Lili Cui, Caiyun Gao, Yuying Su, Yajuan Hu, Hongbo Chen

{"title":"To Accelerate the Process of Brain Death Determination in China Through the Strategy and Practice of Establishing Demonstration Hospitals.","authors":"Yingying Su, Weibi Chen, Yan Zhang, Linlin Fan, Gang Liu, Fei Tian, Huijin Huang, Lili Cui, Caiyun Gao, Yuying Su, Yajuan Hu, Hongbo Chen","doi":"10.1007/s12028-023-01908-w","DOIUrl":null,"url":null,"abstract":"Background: Our objective was to explore whether a brain death determination (BDD) strategy with demonstration hospitals can accelerate the process of BDD in China.Methods: We proposed the construction standards for the BDD quality control demonstration hospitals (BDDHs). The quality and quantity of BDD cases were then analyzed.Results: A total of 107 BDDHs were established from 2013 to 2022 covering 29 provinces, autonomous regions, and municipalities under jurisdiction of the central government of the Chinese mainland (except Qinghai and Tibet). A total of 1,948 professional and technical personnel from these 107 BDDHs received training in BDD, 107 quality control personnel were trained in the quality control management of BDD, and 1,293 instruments for electroencephalography, short-latency somatosensory evoked potential recordings, and transcranial Doppler imaging were provided for BDD. A total of 6,735 BDD cases were submitted to the quality control center. Among the nine quality control indicators for BDD in these cases, the implementation rate, completion rate, and coincidence rate of apnea testing increased the most, reaching 99%.Conclusions: The strategy of constructing BDDHs to promote BDD is feasible and reliable. Ensuring quality and quantity is a fundamental element for the rapid and orderly popularization of BDD in China.","PeriodicalId":19118,"journal":{"name":"Neurocritical Care","volume":null,"pages":null},"PeriodicalIF":3.1000,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurocritical Care","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s12028-023-01908-w","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/5 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Our objective was to explore whether a brain death determination (BDD) strategy with demonstration hospitals can accelerate the process of BDD in China.

Methods: We proposed the construction standards for the BDD quality control demonstration hospitals (BDDHs). The quality and quantity of BDD cases were then analyzed.

Results: A total of 107 BDDHs were established from 2013 to 2022 covering 29 provinces, autonomous regions, and municipalities under jurisdiction of the central government of the Chinese mainland (except Qinghai and Tibet). A total of 1,948 professional and technical personnel from these 107 BDDHs received training in BDD, 107 quality control personnel were trained in the quality control management of BDD, and 1,293 instruments for electroencephalography, short-latency somatosensory evoked potential recordings, and transcranial Doppler imaging were provided for BDD. A total of 6,735 BDD cases were submitted to the quality control center. Among the nine quality control indicators for BDD in these cases, the implementation rate, completion rate, and coincidence rate of apnea testing increased the most, reaching 99%.

Conclusions: The strategy of constructing BDDHs to promote BDD is feasible and reliable. Ensuring quality and quantity is a fundamental element for the rapid and orderly popularization of BDD in China.

Abstract Image

查看原文本刊更多论文

通过建立示范医院的战略和实践，加快中国脑死亡鉴定的进程。

背景：我们的目的是探讨以示范医院为基础的脑死亡判定（BDD）策略能否加快中国脑死亡判定的进程：我们的目的是探讨以示范医院为基础的脑死亡判定（BDD）战略能否加快中国脑死亡判定的进程：方法：我们提出了脑死亡判定质量控制示范医院（BDDHs）的建设标准。方法：我们提出了死亡质量控制示范医院（BDDH）的建设标准，并对BDD病例的质量和数量进行了分析：结果：2013 年至 2022 年，全国共建成 107 家 BDD 质量控制示范医院，覆盖全国 29 个省、自治区、直辖市（青海、西藏除外）。这 107 家 BDDH 共有 1 948 名专业技术人员接受了 BDD 培训，107 名质控人员接受了 BDD 质控管理培训，并为 BDD 提供了 1 293 台脑电图、短时体感诱发电位记录和经颅多普勒成像仪器。质控中心共收到 6,735 个 BDD 病例。在这些病例的 BDD 九项质控指标中，呼吸暂停检测的执行率、完成率和吻合率的增幅最大，达到 99%：构建 BDDHs 以促进 BDD 的策略是可行且可靠的。结论：构建 BDDH 来推广 BDD 的策略是可行的、可靠的，保质保量是在中国快速有序地推广 BDD 的基本要素。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Neurocritical Care 医学-临床神经学

CiteScore

7.40

自引率

8.60%

发文量

221

审稿时长

4-8 weeks

期刊介绍： Neurocritical Care is a peer reviewed scientific publication whose major goal is to disseminate new knowledge on all aspects of acute neurological care. It is directed towards neurosurgeons, neuro-intensivists, neurologists, anesthesiologists, emergency physicians, and critical care nurses treating patients with urgent neurologic disorders. These are conditions that may potentially evolve rapidly and could need immediate medical or surgical intervention. Neurocritical Care provides a comprehensive overview of current developments in intensive care neurology, neurosurgery and neuroanesthesia and includes information about new therapeutic avenues and technological innovations. Neurocritical Care is the official journal of the Neurocritical Care Society.